Status:
COMPLETED
Safety and Efficacy Study of a Eye Drop for Eye Allergy
Lead Sponsor:
Vistakon Pharmaceuticals
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
10+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy eyedrop.
Eligibility Criteria
Inclusion
- At least 10 years of age
- positive history of ocular allergies
- positive skin test reaction to allergens.
Exclusion
- known allergy, contraindication, or sensitivities to the use of any of the study medication(s) or their components
- ocular surgical intervention within three (3) months prior to visit 1 or during the study
- known history of retinal detachment, diabetic retinopathy, or progressive retinal disease, or glaucoma
- any other significant illness
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00889330
Start Date
April 1 2009
Last Update
March 6 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fairfield, Ohio, United States
2
Mason, Ohio, United States